The Food and Drug Administration has given the regulatory greenlight to IDX Systems for its IDXview image management product.IDXview represents the Burlington, VT, company's effort to expandfrom its base in radiology information systems into digital
The Food and Drug Administration has given the regulatory greenlight to IDX Systems for its IDXview image management product.IDXview represents the Burlington, VT, company's effort to expandfrom its base in radiology information systems into digital imagemanagement, according to Britt Cummings, manager of radiologysystems.
IDXview is based on Digital Equipment Alpha workstation architecturerunning an X-Windows operating system with 1k x 1k display monitors.It is DICOM-compliant and can be integrated with the company'sIDXrad RIS product, making it one of the first commercially availableintegrated RIS/image management solutions.
IDXview is not a PACS product, Cummings said, because it lacksthe 2k x 2k monitor technology required for primary diagnosis.Instead, IDX will market the system as ideal for consultationand review between radiology departments and referring physiciansin other areas. A primary diagnosis component can be added vialinks to PACS products from other vendors, he said.
IDX will emphasize the integrated nature of the RIS and imagemanagement system in marketing IDXview. IDXrad has a sophisticatedsearch engine that makes it easy for physicians to locate andsort patient data, according to Cummings.
"Because we are so tied to the RIS, we have some verysimple and efficient searches to find the patient (physicians)are looking for," Cummings said.
There are two beta sites using IDXview and the company is readyto begin shipping the product.
MRI-Based AI Radiomics Model Offers 'Robust' Prediction of Perineural Invasion in Prostate Cancer
July 26th 2024A model that combines MRI-based deep learning radiomics and clinical factors demonstrated an 84.8 percent ROC AUC and a 92.6 percent precision-recall AUC for predicting perineural invasion in prostate cancer cases.
Breast MRI Study Examines Common Factors with False Negatives and False Positives
July 24th 2024The absence of ipsilateral breast hypervascularity is three times more likely to be associated with false-negative findings on breast MRI and non-mass enhancement lesions have a 4.5-fold likelihood of being linked to false-positive results, according to new research.
Can Polyenergetic Reconstruction Help Resolve Streak Artifacts in Photon Counting CT?
July 22nd 2024New research looking at photon-counting computed tomography (PCCT) demonstrated significantly reduced variation and tracheal air density attenuation with polyenergetic reconstruction in contrast to monoenergetic reconstruction on chest CT.